This AP story raises many important questions about the quality of information consumers receive (or not) about the quality of care. Excerpt:
“Millions of seniors signed up for popular Medicare Advantage insurance plans don’t get the best quality, an independent study found.
…
The analysis found that 47 percent of Medicare beneficiaries are in plans that rate three stars or two — medium to fair quality. Just 23 percent were signed up in plans that rate four or five stars — very good to excellent quality. Many of the rest were in plans not yet rated.”
Are consumers not aware of the ratings?
Not receiving them?
Not understanding them?
Not trusting them?
These are important questions for journalists to investigate.
Opinions on other issues in news, journals, PR, advertising, marketing
Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's @CarlaKJohnson. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d
Come on, NY Times; you must do better than this. Important research doesn’t need hype and the “breaking news” BS doesn’t help readers or patients. https://www.healthnewsreview.org/2022/03/nyt-proclaims-breaking-news/
Comments (2)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Diane
May 13, 2010 at 7:49 pmThe insurance plans for seniors are very confusing and frustrating and when you do select a plan you don’t get much support from the company you choose.
My husband choose U Care of MN when he turned 65 last fall. All was well until January U Care changed the prescription provider for mail order. He has been on the phone every week trying to get things straightened out. His doctor is ready to tell him to jump in the lake because the new company keeps wanting a new prescription almost every week.
It’s just nuts. Luckily he has only 1 prescription. I can’t imagine what it’s like for people who have several to keep track of without getting screwed by the insurance company.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like